QLF3108
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 31, 2023
A Study of QLF3108 in Participants With Advanced Solid Tumor
(clinicaltrials.gov)
- P1 | N=78 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1